| Jabbour E, Jones D, Kantarjian HM, et al.
Long-term outcome of patients with chronic myeloid leukemia treated with second generation tyrosine kinase inhibitors after imatinib failure is predicted by the in vitro sensitivity of BCR-ABL kinase domain mutations. [JOURNAL ARTICLE]
Blood 2009 Jun 30.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 May; 31(4):263-98.
Abstract | Full Citation |
| Tomillero A, Moral MA
Gateways to clinical trials. [Journal Article]
Methods Find Exp Clin Pharmacol 2009 Apr; 31(3):183-227.
Abstract | Full Citation |
| Aguilera DG, Tsimberidou AM
Dasatinib in chronic myeloid leukemia: a review. [Journal Article]
Ther Clin Risk Manag 2009 Apr; 5(2):281-9.
Abstract | Full Citation |
| Parkkila S, Innocenti A, Kallio H, et al.
The protein tyrosine kinase inhibitors imatinib and nilotinib strongly inhibit several mammalian alpha-carbonic anhydrase isoforms. [JOURNAL ARTICLE]
Bioorg Med Chem Lett 2009 Jun 6.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Mauro MJ
Response Dynamics in Chronic-Phase Chronic Myeloid Leukemia. [JOURNAL ARTICLE]
Clin Lymphoma Myeloma 2009 Jun 1; 9(3):217-222.
Abstract | Full Citation | Find Related Articles |
| Baldazzi C, Luatti S, Marzocchi G, et al.
Emergence of clonal chromosomal abnormalities in Philadelphia negative hematopoiesis in chronic myeloid leukemia patients treated with nilotinib after failure of imatinib therapy. [LETTER]
Leuk Res 2009 Jun 12.
Full Citation | Publisher Full Text | Find Related Articles |
| Breccia M, Alimena G
Nilotinib Therapy in Chronic Myelogenous Leukemia: The Strength of High Selectivity on BCR/ABL. [Journal Article]
Curr Drug Targets 2009 Jun; 10(6):530-6.
Abstract | Full Citation |
| Haouala A, Zanolari B, Rochat B, et al.
Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry. [JOURNAL ARTICLE]
J Chromatogr B Analyt Technol Biomed Life Sci 2009 May 13.
Abstract | Full Citation |
| Hadzijusufovic E, Peter B, Rebuzzi L, et al.
Growth-inhibitory effects of four tyrosine kinase inhibitors on neoplastic feline mast cells exhibiting a Kit exon 8 ITD mutation. [JOURNAL ARTICLE]
Vet Immunol Immunopathol 2009 May 18.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
  |
